Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hyperandrogenism × bicalutamide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 115 Breast Neoplasms 10 Neoplasm Metastasis 6 Neoplasms 5 Triple Negative Breast Neoplasms 4 Bulbo-Spinal Atrophy, X-Linked 4 Salivary Gland Neoplasms 2 Osteoporosis 2 Lower Urinary Tract Symptoms 2 Hirsutism 2 Thrombocytosis 1 Stage I Prostate Adenocarcinoma AJCC v7 1 Stage I Prostate Adenocarcinoma 1 Sexual Dysfunction, Physiological 1 Recurrence 1 Prostate Adenocarcinoma 1 Primary Myelofibrosis 1 Primary Dysautonomias 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycystic Ovary Syndrome 1 Pancreatic Neoplasms 1 Paget Disease, Extramammary 1 PSA Level Greater Than Two 1 Ovarian Neoplasms 1 Non-Muscle Invasive Bladder Neoplasms 1 Non Castrate Metastatic Prostate Cancer 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1

Interventions

Metformin 7 Progesterone 5 Spironolactone 4 drospirenone and ethinyl estradiol combination 3 Inositol 3 Ethinyl Estradiol 3 salicylsalicylic acid 2 Folic Acid 2 Flutamide 2 Cyproterone Acetate 2 Clomiphene 2 maltodextrin 1 licogliflozin 1 bicalutamide 1 Yoga 1 Waist-Hip Ratio 1 Waist Circumference 1 Ultrasonography 1 Topiramate 1 Time 1 Thioctic Acid 1 Sugars 1 Sodium Salicylate 1 Physical Examination 1 Phlebotomy 1 Phenotype 1 Ovidrel 1 Magnesium 1 Lactalbumin 1 Inulin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05647356 2022-12-12

REFUEL PCOS

Royal College of Surgeons, Ireland

Phase NA Unknown

Metabolic Diseases, Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡